Gastroenteropancreatic Neuroendocrine Neoplasms
📧 Sign up to get email alerts when something new happens for Gastroenteropancreatic Neuroendocrine Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: A Phase I Study to Assess the Safety and Efficacy of [225Ac]Ac-DOTATATE in Patients With SSTR+ GEP-Nens [Phase 1]
Phase I clinical trial evaluating safety and preliminary efficacy of [225Ac]Ac-DOTATATE in somatostatin receptor–positive gastroenteropancre…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Correlation Between Body Composition and Pathologic Grade/Prognosis in GEP-NENs: A Retrospective Study
A retrospective study examining the relationship between body composition and pathologic grade/prognosis in gastroenteropancreatic neuroendo…
-
CLINICAL_TRIALS research · 2024-07-25Clinical Trial Update: Generation of Organoids of Neuroendocrine Neoplasms of the Gastro-Entero-Pancreatic Tract Obtained From Patients Undergoing Surgery
This clinical trial aims to generate organoids from gastroenteropancreatic neuroendocrine neoplasms using tissue from patients undergoing su…
-
CLINICAL_TRIALS research · 2016-07-20Clinical Trial Update: Identification of Biomarker Profiles GEP-NEN Patients
This clinical trial update reports research identifying biomarker profiles in patients with gastroenteropancreatic neuroendocrine neoplasms,…